Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Is higher population-level use of ICS/LABA combination associated with better asthma outcomes? Cross-sectional surveys of nationally representative populations in New Zealand and Australia.

Reddel HK, Beckert L, Moran A, Ingham T, Ampon RD, Peters MJ, Sawyer SM.

Respirology. 2017 Nov;22(8):1570-1578. doi: 10.1111/resp.13123. Epub 2017 Aug 9.

PMID:
28791752
2.

Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.

Wechsler ME, Yawn BP, Fuhlbrigge AL, Pace WD, Pencina MJ, Doros G, Kazani S, Raby BA, Lanzillotti J, Madison S, Israel E; BELT Investigators.

JAMA. 2015 Oct 27;314(16):1720-30. doi: 10.1001/jama.2015.13277.

PMID:
26505596
3.

The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis.

Pavord ID, Mathieson N, Scowcroft A, Pedersini R, Isherwood G, Price D.

NPJ Prim Care Respir Med. 2017 Mar 9;27(1):17. doi: 10.1038/s41533-017-0014-1. Erratum in: NPJ Prim Care Respir Med. 2017 Dec 5;27(1):65.

4.

Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.

Kondla A, Glaab T, Pedersini R, Lommatzsch M.

Respir Med. 2016 Sep;118:58-64. doi: 10.1016/j.rmed.2016.07.012. Epub 2016 Jul 16.

5.

Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.

Blanchette CM, Culler SD, Ershoff D, Gutierrez B.

Clin Ther. 2009 Nov;31(11):2574-83. doi: 10.1016/j.clinthera.2009.11.007.

PMID:
20110003
6.

Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.

Sadatsafavi M, Lynd LD, Marra CA, FitzGerald JM.

Thorax. 2014 Apr;69(4):328-34. doi: 10.1136/thoraxjnl-2013-203998. Epub 2013 Nov 26.

PMID:
24281327
7.

Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial).

Keith PK, Koch C, Djandji M, Bouchard J, Psaradellis E, Sampalis JS, Schellenberg RR, McIvor RA.

Can Respir J. 2009 May-Jun;16 Suppl A:17A-31A. English, French.

8.

Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.

Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.

Curr Med Res Opin. 2009 Sep;25(9):2251-8. doi: 10.1185/03007990903155915.

PMID:
19622006
9.

One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.

Sadatsafavi M, Lynd LD, De Vera MA, Zafari Z, FitzGerald JM.

Respir Med. 2015 Mar;109(3):320-8. doi: 10.1016/j.rmed.2014.12.014. Epub 2015 Jan 7.

10.
11.

The relationship between clinical outcomes and medication adherence in difficult-to-control asthma.

Murphy AC, Proeschal A, Brightling CE, Wardlaw AJ, Pavord I, Bradding P, Green RH.

Thorax. 2012 Aug;67(8):751-3. doi: 10.1136/thoraxjnl-2011-201096. Epub 2012 Mar 21.

PMID:
22436168
12.

Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.

Dal Negro RW, Borderias L, Zhang Q, Fan T, Sazonov V, Guilera M, Taylor SD.

BMC Pulm Med. 2009 Mar 30;9:10. doi: 10.1186/1471-2466-9-10.

13.

Economic Burden Associated with Receiving Inhaled Corticosteroids with Leukotriene Receptor Antagonists or Long-Acting Beta Agonists as Combination Therapy in Older Adults.

Altawalbeh SM, Thorpe CT, Zgibor JC, Kane-Gill S, Kang Y, Thorpe JM.

J Manag Care Spec Pharm. 2018 May;24(5):478-486. doi: 10.18553/jmcp.2018.24.5.478.

14.

A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting beta-agonists and corticosteroids.

Elkout H, McLay JS, Simpson CR, Helms PJ.

Arch Dis Child. 2010 Oct;95(10):817-21. doi: 10.1136/adc.2009.179069. Epub 2010 Jul 23.

PMID:
20656730
15.

Adherence to anti-inflammatory treatment for asthma in clinical practice in France.

Latry P, Pinet M, Labat A, Magand JP, Peter C, Robinson P, Martin-Latry K, Molimard M.

Clin Ther. 2008;30 Spec No:1058-68. doi: 10.1016/j.clinthera.2008.06.011.

PMID:
18640480
16.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.

17.

Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.

Hozawa S, Terada M, Haruta Y, Hozawa M.

Pulm Pharmacol Ther. 2016 Apr;37:15-23. doi: 10.1016/j.pupt.2016.01.005. Epub 2016 Feb 2.

PMID:
26850307
18.

Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.

Israel E, Roche N, Martin RJ, Colice G, Dorinsky PM, Postma DS, Guilbert TW, van Aalderen WM, Grigg J, Hillyer EV, Burden A, von Ziegenweidt J, Thomas V, Price DB.

Ann Am Thorac Soc. 2015 Jun;12(6):798-806. doi: 10.1513/AnnalsATS.201412-580OC.

PMID:
25756308
19.

Asthma control in Australia: a cross-sectional web-based survey in a nationally representative population.

Reddel HK, Sawyer SM, Everett PW, Flood PV, Peters MJ.

Med J Aust. 2015 May 18;202(9):492-7.

PMID:
25971575
20.

Long-acting β2-agonist step-off in patients with controlled asthma.

Brozek JL, Kraft M, Krishnan JA, Cloutier MM, Lazarus SC, Li JT, Santesso N, Strunk RC, Casale TB.

Arch Intern Med. 2012 Oct 8;172(18):1365-75. Review.

PMID:
22928176

Supplemental Content

Support Center